Merck

Merck reveals 7 years of its U.S. drug price increase history
Yahoo/Reuters
Sat, 01/28/17 - 02:57 pm
Merck
drug pricing
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:39 pm
Merck
Sanofi
Eli Lilly
Pfizer
Roche
AstraZeneca
Gilead Sciences
Allergan
GSK
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Bristol-Myers Squibb
Merck
Roche
Gilead Sciences
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Mon, 01/23/17 - 11:11 am
Merck
Keytruda
Bristol-Myers Squibb
Ono Pharmaceutical
Opdivo
patents
Pharma joins Gates Foundation, international governments in $1B outbreak prep group
Fierce Pharma
Sun, 01/22/17 - 01:43 pm
Gates Foundation
GSK
Merck
JNJ
Pfizer
Sanofi
Takeda
R&D
epidemics
Merck Awaits News On Free Win With High Risk Heart Drug
Seeking Alpha
Sun, 01/22/17 - 01:33 pm
Merck
Anacetrapib
Bristol-Myers Falls Further Behind Merck in Lung Cancer Race
Bloomberg
Thu, 01/19/17 - 11:32 pm
Bristol-Myers Squibb
Merck
lung cancer
Keytruda
Opdivo
How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016
Motley Fool
Thu, 01/19/17 - 11:26 am
JNJ
pharma stocks
AbbVie
Merck
The Top 5 Drug Patents Expiring in 2017
Investopedia
Mon, 01/16/17 - 11:48 am
patents
Novartis
Eli Lilly
Merck
Bristol-Myers Squibb
Sandostatin LAR
Cubicin
Reyataz
Vytorin
Strattera
Merck Is Best Performing DJIA Stock So Far in 2017
Yahoo/24-7 Wall St
Mon, 01/16/17 - 10:37 am
Merck
Dow Jones
Merck shares rise after hours on priority review lung cancer drug application
Marketwatch
Wed, 01/11/17 - 10:11 am
Merck
Keytruda
lung cancer
priority review
FDA
Lilly and Merck Expand Immuno-Oncology Collaboration
Yahoo
Wed, 01/11/17 - 10:05 am
Eli Lilly
Merck
immuno-oncology
Lartruvo
Keytruda
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
M&A
Gilead Sciences
JNJ
Pfizer
Merck
Novartis
Eli Lilly
Bristol-Myers Squibb
Biogen
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Motley Fool
Sun, 01/8/17 - 03:18 pm
Merck
Keytruda
Opdivo
Bristol-Myers Squibb
Zepatier Should Boost Merck’s Profit Margins in the Future
Market Realist
Mon, 01/2/17 - 12:00 pm
Merck
Zepatier
hepatitis C
Merck’s Zetia and Vytorin: More Generic Competition in 2017
Market Realist
Thu, 12/29/16 - 12:28 pm
Merck
Vytorin
generics
This Army Vet Is Fighting Hep C With Big Pharma’s Help
Bloomberg
Thu, 12/29/16 - 10:18 am
hepatitis C
AbbVie
Merck
Gilead Sciences
Merck Continues to Dominate with Its Januvia Franchise
Market Realist
Thu, 12/29/16 - 10:04 am
Merck
Januvia
diabetes
Keytruda Is Still a Strong Growth Driver for Merck
Market Realist
Wed, 12/28/16 - 07:32 pm
Keytruda
Merck
Merck’s Ebola vaccine promises to stop the next outbreak in its tracks
Endpoints
Sat, 12/24/16 - 12:16 pm
Merck
ebola virus
vaccines
rVSV-ZEBOV

Pages